Suzanne D. Vernon, PhD
Suzanne D. Vernon , PhD, is the Research Liaison at Bateman Horne Center of Excellence which specializes in treatment and research for ME/CFS and Fibromyalgia and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of microbiome samples for research and development.
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of Solve ME/CFS Initiative, formerly known as CFIDS Association of America. While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/ CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/ CFS. The core of RIWW is the SolveCFS BioBank & Patient Registry.
From May 1990 to October 2007, Dr. Vernon worked for the US Centers for Disease Control , first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under William Reeves , MD, the Director of the CDC Chronic Fatigue Research Program.
In 2005, Dr Vernon was one of the authors of the CDC case definition of CFS , commonly called the Reeves criteria .
